UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely BiondVax is implementing good security practices.
BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company developing a universal influenza vaccine called M-001.
This report shows a preliminary security rating for BiondVax. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Formulating an IT security risk assessment methodology is a key part of building a robust ...
Common Vulnerabilities and Exposures (CVE) is a list of publicly disclosed information security ...
Compare BiondVax's security performance with other companies